[ad_1]
The entrepreneur João Alves Queiroz Filho, founder of Hypera Pharma (formerly Hypermarcas), and Claudio Bergamo, former president of the company, are in talks to try to make a recommendation to the Attorney General's Office ( PGR), according to three sources with the subject. On another front, the group is also discussing a leniency agreement, as the state anticipated in April.
Queiroz and Bergamo left the company at the end of April. The group makes acquisitions since 2010 to take the lead of the drugs "src =" https://p2.trrsf.com/image/fget/cf/460/0/images.terra.com/2018/06/29/1442788038056 .jpg "title =" Grupo pbadou a fazer aquisces desde 2010 para liderar em medicamentos "width =" 460 "/>
The group began making acquisitions of 2010 lead in drugs
Content
It is expected that negotiations for a possible indulgence and leniency will end in the coming days.
Created to be a Brazilian Unilever, Hypera had the name involved for the first time in Operation Lava Jato in Brazil. June 2015, after the state leaked excerpts from the collaboration agreement of former director of institutional relations group, Nelson Mello. According to the testimony of the former director, the company reportedly transferred approximately 30 million reais to MDB members through operators Lúcio Funaro and Milton Lyra.
The objectives would be to guarantee the performance of these politicians in terms of corporate interests in Congress. In the Mello indictment, the initiative and any liability for the illegal payments was his and the company was not aware of the transactions.
It happens that the demarcation of Mello may be canceled because the former executive would have omitted information to save Queiroz and Bergamo. Sources on the subject said that the founder and former chairman of the group would be willing to detail payments made to parliamentarians who helped open the doors of Hypera in Brasilia, particularly at the National Health Surveillance Agency (Anvisa). ), and also facilitated the granting of Tax Advantages to Goiás, head office
In April, the lawyer Celso Vilardi was hired to defend Hypera. The criminal has already concluded agreements with important entrepreneurs, such as Camargo Corrêa and Andrade Gutierrez. Lawyer José Luís Oliveira Lima, of Oliveira Lima, Hungary, Dall & Acqua & Furrier Advogados, represents the founder of the company. Bergamo is defended by Sérgio Rosenthal of Rosenthal Advogados Associados.
Wanted, Vilardi, Oliveira, Rosenthal, Hypera and PGR do not comment on the subject. Funaro's defense also declined to comment. Lyra's report indicated that his client had provided clarification to the court. Mello's office did not return the interview requests.
Lean. Created to be a giant of national consumer goods, the company was defeated in the last years of its hygiene and beauty business (it became the owner of the Monange, Perfex and Assolan brands) and food badets (such as Etti and Salsaretti) to focus on drugs.
In 2015, Hypera became the deputy leader of medicines in Brazil, after heavy acquisitions – including Neo Química -, surpbading the multinationals.
Remember. Hypera Pharma announced on April 26 that Claudio Bergamo, then president of the company, and his main shareholder and founder, João Alves de Queiroz Filho, Junior, were gone. Two leaders of the group were appointed: Breno de Oliveira, chief financial officer, who took the place of Bergamo, and Luiz Violland, who was in charge of the presidency of the company's management, a position previously held by the owner of the company. (f, b, e, v, n, t, s) {if (f.fbq) returns; n = f.fbq = function () {n.callMethod?
n.callMethod.apply (n, arguments): n.queue.push (arguments)}; if (! f._fbq) f._fbq = n;
n.queue = n.loaded = n.loaded = 0, n.version = 2.0 & # 39 ;; n.queue = []; t = b.createElement (e); t.async =! 0;
t.src = v; s = b.getElementsByTagName (e) [0]; s.parentNode.insertBefore (t, s)} (window,
document, "script", https: //connect.facebook.net/en_US/fbevents.js');
fbq (& # 39 ;, & # 39; 695146213959045 & # 39;);
fbq ("track", "Pageview");
[ad_2]
Source link
